David Kideckel

David Kideckel

Chairman at PHARMADRUG INC.

Net worth: - $ as of 2024-03-30

Consumer Services
Finance
Health Technology

Profile

David M.
Kideckel
is currently the Chairman at Pharmadrug, Inc., the Senior VP, Head-Corporate Development & Strategic at IntelGenx Technologies Corp., and the EVP, Head-Strategy & Corporate Development at Delta 9 Cannabis, Inc. Previously, he worked as an Analyst & Managing Director at ATB Capital Markets, Inc. from 2018 to 2021.
He also held the position of Director of Equity Research at Beacon Securities Ltd.
Dr. Kideckel holds an MBA from Rotman School of Management and a doctorate from the University of Toronto.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-03 0 ( -.--% ) - $ 2024-03-30
2023-11-06 0 ( -.--% ) - $ 2024-03-30

David Kideckel active positions

CompaniesPositionStart
DELTA 9 CANNABIS INC. Corporate Officer/Principal 2021-08-15
PHARMADRUG INC. Chairman 2024-02-26
INTELGENX TECHNOLOGIES CORP. Corporate Officer/Principal 2023-03-19
All active positions of David Kideckel

Former positions of David Kideckel

CompaniesPositionEnd
Analyst-Equity 2021-07-31
Director of Research - Equity -
See the detail of David Kideckel's experience

Training of David Kideckel

Rotman School of Management Masters Business Admin
University of Toronto Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kideckel's experience

Connections

56

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INTELGENX TECHNOLOGIES CORP.

Health Technology

DELTA 9 CANNABIS INC.

Distribution Services

Private companies3

Finance

Finance

Pharmadrug, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. David Kideckel